SNAP-8 Protocol
Acetyl octapeptide studied topically for expression-line and neuromuscular signaling research in skin.
- Cycle
- 8–12 weeks
Evidence Level: Investigational / Theoretical
Primarily preclinical or very limited human data — mechanism-based reasoning more than a demonstrated clinical effect. Treat as investigational.
Human evidence: Cosmetic-industry sponsored topical trials measuring wrinkle-depth outcomes; not independently replicated in large clinical programs.
Animal evidence: Limited — mechanism largely derived from cell-culture SNARE-complex studies.
Introduction & Mechanism of Action
Acetyl octapeptide studied topically for expression-line and neuromuscular signaling research in skin.
Modeled on SNAP-25 (a SNARE-complex protein involved in neurotransmitter release); topical application is studied for reducing acetylcholine-mediated muscle-contraction signaling at the skin surface.
Receptors/targets: SNARE complex (SNAP-25 competitive interaction) — not a classical cell-surface receptor
Areas of Research Interest
- Expression-line research
- Topical anti-aging studies
Benefits Reported in Research
- Expression-line research
- Topical anti-aging studies
Reported Research Dosing Range
The figures below are cited from published research literature and protocol references — they describe what has been studied, not a personal prescription or instruction.
Reported range: Structured dosing data unavailable
Reported frequency: 1–2× daily, topical
Reported cycle duration: 8–12 weeks
Escalation & maintenance: A dedicated weekly escalation and maintenance schedule specific to this peptide has not yet been published here — follow the dose range and frequency above, titrating conservatively from the low end, and consult a physician before adjusting.
Side Effects
- Mild topical irritation
- Redness at application site
Contraindications
- Known sensitivity to the ingredient
- Broken or irritated skin at the application site
Drug interactions
- None well characterized — topical cosmetic-category ingredient
Safety
- Topical irritation in sensitive skin
- Minimal systemic risk given non-injectable route
Evidence is largely from cosmetic-industry studies of topical formulations, not injectable clinical trials.
Expected Results & Comparison
SNAP-8 targets muscle-contraction signaling (a "topical Botox-like" research angle), while GHK-Cu targets extracellular-matrix remodeling — different mechanisms for different skin-aging research questions, not directly comparable in potency.